Risk of bleeding with dabigatran in atrial fibrillation
I Hernandez, SH Baik, A Piñera… - JAMA internal medicine, 2015 - jamanetwork.com
Importance It remains unclear whether dabigatran etexilate mesylate is associated with
higher risk of bleeding than warfarin sodium in real-world clinical practice. Objective To
compare the risk of bleeding associated with dabigatran and warfarin using Medicare data.
Design, Setting, and Participants In this retrospective cohort study, we used pharmacy and
medical claims in 2010 to 2011 from a 5% random sample of Medicare beneficiaries. We
identified participants as those newly diagnosed as having atrial fibrillation from October 1 …
higher risk of bleeding than warfarin sodium in real-world clinical practice. Objective To
compare the risk of bleeding associated with dabigatran and warfarin using Medicare data.
Design, Setting, and Participants In this retrospective cohort study, we used pharmacy and
medical claims in 2010 to 2011 from a 5% random sample of Medicare beneficiaries. We
identified participants as those newly diagnosed as having atrial fibrillation from October 1 …